Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOLFOXIRI Regimen”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Large-scale testing (Phase 3)UnknownNCT02355119
What this trial is testing

Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Azienda Ospedaliero, Universitaria Pisana 310
Not applicableStudy completedNCT06048146
What this trial is testing

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

Who this might be right for
Lymph Node MetastasisCancer of Rectum and AnusOxaliplatin+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Testing effectiveness (Phase 2)Study completedNCT03085992
What this trial is testing

Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Azienda Ospedaliero, Universitaria Pisana 49
Testing effectiveness (Phase 2)Study completedNCT02497157
What this trial is testing

Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890624
What this trial is testing

MFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer (Stage II &Amp;Amp; III)
Sun Yat-sen University 138
Large-scale testing (Phase 3)Looking for participantsNCT05201430
What this trial is testing

Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Fudan University 300
Testing effectiveness (Phase 2)Study completedNCT04072198
What this trial is testing

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

Who this might be right for
Colorectal Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 73
Testing effectiveness (Phase 2)UnknownNCT04838496
What this trial is testing

Induction Chemotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Catharina Ziekenhuis Eindhoven 128
Large-scale testing (Phase 3)Study completedNCT01640405
What this trial is testing

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 350
Testing effectiveness (Phase 2)UnknownNCT03484195
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

Who this might be right for
Colonic NeoplasmsDrug Therapy
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT01358812
What this trial is testing

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colo-rectal Cancer
Gruppo Oncologico del Nord-Ovest 37
Not applicableStudy completedNCT03504618
What this trial is testing

Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI

Who this might be right for
Colorectal Cancer
Hanoi Medical University 39
Testing effectiveness (Phase 2)Study completedNCT02217020
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT03641976
What this trial is testing

Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer

Who this might be right for
Unresectable Metastatic Right-sided Colon Cancer Starting First-line Combination ChemotherapyUnresectable Metastatic Right-sided Colon Cancer, Stage IV
Yonsei University 120
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Testing effectiveness (Phase 2)UnknownNCT05200299
What this trial is testing

MFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Who this might be right for
Colorectal Cancer
First Affiliated Hospital of Wenzhou Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02271464
What this trial is testing

Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 232
Testing effectiveness (Phase 2)Study completedNCT00689624
What this trial is testing

Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital of Crete 30
Testing effectiveness (Phase 2)Looking for participantsNCT05727163
What this trial is testing

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT03493048
What this trial is testing

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Who this might be right for
Colorectal CancerLiver Metastases
Sun Yat-sen University 146
Next Page